1 Global Medicinal Mushrooms Market Insight Analysis
The global medicinal mushrooms market is valued at USD 375.89 million in 2024, with a CAGR of 6.80% from 2024 to 2033.
Medical Mushrooms are mushrooms that are used or can potentially be used in the future to make medical drugs. They contain one or more compounds that can have various health benefits as well, such as antiviral or anti-senescence properties. Many medical mushrooms also contain adapt genic properties which are under study, such as compounds which boost the immune system by stimulating lymphocyte production, or novel anti-inflammatory.
Medical Mushrooms are now increasingly valued for their many important medicinal properties, so much so that they are used not only as dietary food (functional foods) but also in the form of dietary supplements, nutraceuticals, and mycotherapy products, etc.
Figure Global Medicinal Mushrooms Market Size (M USD) and CAGR (2024-2033)
2 Medicinal Mushrooms Market Growth Drivers and Restraints
Health-promoting effects are recognized: Consumers’ increasing awareness of the health benefits of medicinal mushrooms is a key driver of market growth. Medicinal mushrooms are rich in vitamin D, potassium, calcium and other nutrients, which can enhance antioxidant activity and improve the function of the human immune system. At a time when people pay attention to health and wellness, consumers’ demand for functional foods and nutritional health products continues to rise. Medicinal mushrooms are widely used in dietary supplements, functional foods and other fields due to their rich nutritional value and medicinal properties. For example, Ganoderma lucidum and Chaga are added to coffee and cocoa, meeting consumers’ demand for health products.
The rise of vegetarianism: With the popularity of vegetarianism, the plant-based food market has developed rapidly. Medicinal mushrooms, as an important source of nutrition for vegetarians, contain nutrients such as vitamin D, B vitamins, dietary fiber and protein, and are favored by the vegetarian community. According to relevant research, the sales growth rate of plant-based foods in 2021 was three times that of overall foods, which provided new opportunities for the expansion of the medicinal mushroom market.
R&D investment and innovation: The increasing R&D investment in medicinal mushrooms has driven the development of the market. On the one hand, research has found more medicinal ingredients in mushrooms, such as ergosterol in mushrooms, which can be converted into vitamin D after ultraviolet irradiation, and vitamin D2 from mushrooms has been recognized by the European Union, which provides a broader space for the application of medicinal mushrooms in the field of nutritional supplements. On the other hand, companies continue to innovate product forms. For example, Australia’s Fable Food uses shiitake mushrooms to make alternative meat products, enriching the downstream application market of medicinal mushrooms.
Affected by natural factors: The growth of medicinal mushrooms requires high natural conditions such as climate, soil and sunlight. For example, during the growth of Ganoderma lucidum, natural disasters such as drought, floods, insect pests or abnormal temperatures will lead to a decrease in yield or a decrease in effective medicinal ingredients, affecting the supply and quality of raw materials, and thus restricting industrial development.
Risk of raw material quality control: If the production of medicinal mushrooms does not follow standard specifications, it is susceptible to pesticide residues, excessive heavy metals, environmental pollution and other problems during the planting process, and even adulteration and counterfeiting. These unqualified products entering the market will not only harm the health of consumers, but also affect the reputation of the entire industry and hinder the healthy development of the market.
3 Technological Innovations in the Medicinal Mushrooms Market
Product R&D innovation: Enterprises continue to increase their investment in the R&D of medicinal mushroom products and launch a variety of innovative products. For example, Four Sigmatic adds organic Hericium erinaceus and Chaga to coffee to develop coffee products with specific functions; Amino Up Chemical’s AHCC® product extracts ingredients rich in partially acylated α-1,4 glucan from shiitake mycelium through a unique manufacturing process, which is different from traditional mushroom products and meets consumers’ demand for high-quality and functional products.
Advances in extraction technology: Innovation in extraction technology is an important direction for the development of medicinal mushroom technology. Hokkaido Reishi Co uses high-pressure steam extraction, which can retain more active ingredients and reduce waste generation compared to traditional double extraction methods. This advanced extraction technology not only improves the quality and purity of the product, but also improves production efficiency and enhances the competitiveness of enterprises in the market.
Breakthroughs in cultivation technology: In terms of the cultivation of medicinal mushrooms, technology is also constantly improving. Some companies have improved the yield and quality of medicinal mushrooms by optimizing the culture medium formula and improving the cultivation environment control technology. At the same time, research on the cultivation of rare species has also made certain progress, which helps to meet the market demand for high-quality medicinal mushrooms.
Expanding markets and product lines: Companies expand their market share and enrich their product lines through mergers and acquisitions. For example, Hollister entered the emerging field of psychedelic drugs through the acquisition of Alphamind Brands, and acquired the research and development and production capabilities of mushroom products including Cordyceps, Hericium, Chaga and Ganoderma, further expanding its business scope in the medicinal mushroom market.
Enhance competitiveness: Mergers and acquisitions help companies integrate resources and enhance their competitiveness. As an emerging biotechnology company, KÄÄPÄ Biotech has become the largest supplier of medicinal mushrooms in Europe through its own development and market integration. Its Nordic mushroom liquid and powder extracts have occupied a place in the market with high-quality raw materials and innovative sustainable collection solutions.
4 Global Medicinal Mushrooms Market Size by Type
Maitake mushrooms (Grifola frondosa) are known for their health benefits, particularly in boosting the immune system and providing adaptogenic properties. In 2024, the market value for Maitake mushrooms is projected to be 63.52 million USD. This type of mushroom is highly valued for its rich beta-glucan content, which contributes to its immune-boosting effects. Maitake mushrooms are widely used in dietary supplements and functional foods, making them a significant contributor to the overall market revenue.
Shiitake mushrooms (Lentinula edodes) are another important type in the medicinal mushrooms market. In 2024, the market value for Shiitake mushrooms is expected to be 43.57 million USD. Shiitake mushrooms are known for their ability to lower cholesterol and blood pressure, making them popular in both dietary supplements and functional foods. Their rich nutritional profile, including significant levels of vitamins and minerals, further enhances their market appeal.
Reishi mushrooms (Ganoderma lingzhi) are among the most highly valued medicinal mushrooms due to their potent health benefits. In 2024, the market value for Reishi mushrooms is projected to be 207.34 million USD. Reishi mushrooms are known for their antioxidant properties and their ability to strengthen the immune system. They are widely used in traditional medicine and modern pharmaceuticals, contributing significantly to the overall market revenue. Reishi mushrooms are also popular in the personal care and cosmetics industry due to their skin health benefits.
Turkey Tail mushrooms (Trametes versicolor) are another important type in the medicinal mushrooms market. In 2024, the market value for Turkey Tail mushrooms is expected to be 14.48 million USD. These mushrooms are known for their polysaccharide content, which has been shown to have immune-boosting effects. Turkey Tail mushrooms are used in various health supplements and functional foods, contributing to their market value.
Table Global Medicinal Mushrooms Market Size by Type in 2024
Type | Market Size (M USD) 2024 |
|---|---|
Maitake | 63.52 |
Shiitake | 43.57 |
Reishi | 207.34 |
Turkey Tail Mushrooms | 14.48 |
Others | 46.98 |
5 Global Medicinal Mushrooms Market Size by Application
Dietary supplements are a major application area for medicinal mushrooms, valued at 111.99 million USD in 2024. This segment includes pills, capsules, powders, and liquids that incorporate mushroom extracts to provide health benefits such as immune support and anti-inflammatory effects. The growing consumer interest in natural health products drives the demand for mushroom-based supplements.
The pharmaceutical application of medicinal mushrooms is another significant segment, valued at 134.40 million USD in 2024. Medicinal mushrooms are used in the development of drugs due to their potent bioactive compounds, which have been shown to have therapeutic effects. This segment includes the use of mushrooms in the treatment of various ailments, from immune disorders to cancer.
Functional food and beverages represent a growing market for medicinal mushrooms, valued at 80.68 million USD in 2024. This segment includes products such as fortified drinks, snacks, and meals that incorporate medicinal mushrooms to provide additional health benefits. The trend towards healthier eating habits and functional foods has driven the demand for mushroom-infused products.
Personal care and cosmetics is an emerging application area for medicinal mushrooms, valued at 48.81 million USD in 2024. Medicinal mushrooms are used in skincare products due to their antioxidant and anti-inflammatory properties, which can help improve skin health and appearance. The growing interest in natural and organic skincare products has contributed to the demand for mushroom-based cosmetics.
Table Global Medicinal Mushrooms Market Size by Application in 2024
Application | Market Size (M USD) 2024 |
|---|---|
Dietary Supplements | 111.99 |
Pharmaceutical | 134.40 |
Functional Food & Beverages | 80.68 |
Personal Care & Cosmetics | 48.81 |
6 Global Medicinal Mushrooms Market Size by Region
North America is a significant market for medicinal mushrooms, valued at 67.87 million USD in 2024. The region’s strong economy, high consumer awareness of health benefits, and advanced research and development capabilities drive the demand for medicinal mushrooms. The United States and Canada are the main markets, with a focus on dietary supplements and functional foods.
Europe is another major market, valued at 52.72 million USD in 2024. The region’s diverse economy and high demand for natural health products contribute to the market’s growth. European consumers are increasingly interested in medicinal mushrooms for their health benefits, particularly in dietary supplements and pharmaceuticals.
China is the largest market for medicinal mushrooms, valued at 146.06 million USD in 2024. The country’s large population and growing middle class drive the demand for health products. China is also a major producer of medicinal mushrooms, contributing significantly to the global supply. The market is dominated by dietary supplements and functional foods, with a growing interest in pharmaceutical applications.
Japan is a key market for medicinal mushrooms, valued at 53.37 million USD in 2024. The country’s advanced economy and strong tradition of using natural remedies drive the demand for medicinal mushrooms. Japanese consumers are particularly interested in high-quality mushroom products for health and wellness, with a focus on dietary supplements and pharmaceuticals.
The Middle East and Africa market is valued at 6.63 million USD in 2024. While smaller compared to other regions, it is growing due to increasing health awareness and economic development. The region’s market is driven by dietary supplements and functional foods, with a growing interest in pharmaceutical applications.
India is an emerging market for medicinal mushrooms, valued at 17.48 million USD in 2024. The country’s large population and growing middle class drive the demand for health products. India’s market is dominated by dietary supplements and functional foods, with a growing interest in pharmaceutical applications.
South America is a growing market for medicinal mushrooms, valued at 18.54 million USD in 2024. The region’s diverse economy and high demand for natural health products contribute to the market’s growth. South American consumers are increasingly interested in medicinal mushrooms for their health benefits, particularly in dietary supplements and functional foods.
Figure Global Medicinal Mushrooms Market Size (M USD) by Region in 2024
7 Global Medicinal Mushrooms Market Analysis by Major Players
GanoHerb
Company Profile
GanoHerb is a leading company in the global medicinal mushrooms industry, established in 1989. The company has a strong presence in China, where its main manufacturing plants are located. GanoHerb has built a comprehensive industry chain for Reishi Mushroom, focusing on its cultivation, processing, and distribution. The company is known for its commitment to quality and innovation, which has helped it gain a significant market share.
Business Overview
GanoHerb’s business primarily revolves around the production and distribution of high-quality medicinal mushroom products. The company has a global sales network, catering to customers in various regions. Over the years, GanoHerb has invested heavily in research and development to enhance its product offerings and meet the growing demand for natural health products. Its dedication to maintaining high standards of quality and sustainability has positioned it as a trusted brand in the industry.
Product Offered
One of GanoHerb’s flagship products is the Organic Reishi Mushroom Powder. This product is designed to boost the immune system and is marketed as a vegan, all-natural, non-GMO, and gluten-free supplement. It is versatile and can be easily incorporated into daily diets, such as in shakes, smoothies, coffee, and tea. The powder is rich in bioactive compounds that support overall health and well-being, making it a popular choice among health-conscious consumers.
Zhongke Health Industry Group
Company Profile
Zhongke Health Industry Group is a prominent player in the medicinal mushrooms market, founded in 1984. The company is based in China and has a wide distribution network both domestically and internationally. Zhongke Health Industry Group is renowned for its expertise in the production and R&D of Chinese medicine health products. Its commitment to innovation and quality has earned it a reputation as a reliable provider of medicinal mushroom products.
Business Overview
The core business of Zhongke Health Industry Group involves the production and research of health products derived from medicinal mushrooms. The company has a strong focus on Ganoderma spore capsules and Ganoderma spore oil capsules, which are known for their health benefits. Zhongke Health Industry Group has a robust R&D team that continuously works on improving product formulations and developing new products to meet market demands. Their business strategy includes expanding their market reach and enhancing customer satisfaction through high-quality products and services.
Product Offered
A standout product from Zhongke Health Industry Group is the Zhongke Lingzhi Spore Capsules. These capsules are produced using pure physical wall-breaking technology at room temperature, ensuring the preservation of the original composition of Ganoderma lucidum spore powder. The product is designed to improve the body’s immunity and has been proven to have health care functions such as immune regulation and auxiliary tumor suppression. This makes it a valuable addition to the health regimen of consumers looking to enhance their immune system and overall health.
Amino Up Chemical
Company Profile
Amino Up Chemical is a biotechnology company that has been at the forefront of innovation in the medicinal mushrooms industry since its establishment in 1984. The company is headquartered in Japan and has a global presence, with its main manufacturing plants located in Japan. Amino Up Chemical is dedicated to developing and commercializing novel natural bioactive compounds derived from medicinal mushrooms. Their commitment to scientific research and product development has positioned them as a leader in the industry.
Business Overview
Amino Up Chemical’s business is centered around the development and production of high-quality medicinal mushroom products. The company collaborates with prestigious universities and clinics worldwide to conduct clinical and basic research on its products. This approach ensures that their products are backed by scientific evidence and meet the highest standards of quality. Amino Up Chemical’s business strategy includes continuous innovation and the expansion of its product portfolio to cater to the evolving needs of the health and wellness market.
Product Offered
One of Amino Up Chemical’s notable products is AHCC® (Active Hexose Correlated Compound). This product is derived from the mycelia of Lentinula edodes, commonly known as Shiitake mushrooms. Unlike typical mushroom products that are rich in beta-glucans, AHCC® is unique due to its high content of partly acylated alpha-1,4 glucans. This proprietary manufacturing process results in a product that offers significant health benefits, including immune system support and overall health enhancement. AHCC® is widely recognized for its effectiveness and is a popular choice among consumers seeking natural health solutions.